May 29 (Reuters) - Medigard Ltd (MGZ) : SIGNED COMMERCIAL AGREEMENT WITH BIO-LINK AUSTRALIA TO ASSIST MEDIGARD WITH NEW TECHNOLOGY MANAGEMENT AND COMMERCIALISATION PROGRAM
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
